ZURICH, Dec 18 (Reuters) - Swiss pharma giants Novartis (NOVN.S), opens new tab and Roche (ROG.S), opens new tab on Thursday backed U.S. efforts to lower the cost of drugs and are working with the ...
LONDON, Dec 10 (Reuters) - Roche (ROG.S), opens new tab said on Wednesday its experimental oral drug giredestrant reduced the risk of breast cancer recurrence by 30% compared with standard endocrine ...
Roche said its giredestrant drug reduced the risk of disease recurrence or death from breast cancer, suggesting potential for the medication to become standard-of-care when the disease is in the ...
Roche has lifted the lid on the data behind its second phase 3 giredestrant win, linking the oral selective estrogen receptor degrader (SERD) to a 30% reduction in the risk of invasive disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback